95P: Adagrasib (ADA) plus cetuximab (CETUX) in patients (pts) with advanced KRASG12C-mutated non-small cell lung cancer (NSCLC) from KRYSTAL-1

20251 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Journal of Thoracic Oncology

Volume 20, Issue 3, pp. S68-S69

Field-Weighted Citation Impact: 1.50